BMS 299897
BMS 299897 is a sulfonamide γ-secretase inhibitor with an IC50 of 7 nM for Aβ production inhibition in HEK293 cells stably overexpressing amyloid precursor protein (APP) .
Product Specifications
CAS Number
290315-45-6
UNSPSC
12352005
Hazard Statement
H302, H319
Target
γ-secretase
Type
Reference compound
Related Pathways
Neuronal Signaling; Stem Cell/Wnt
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/BMS-299897.html
Purity
99.64
Solubility
DMSO : ≥ 30 mg/mL
Smiles
FC1=CC=C(F)C(N([C@@H](C2=C(CCCC(O)=O)C=C(F)C=C2)C)S(C3=CC=C(Cl)C=C3)(=O)=O)=C1
Molecular Formula
C24H21ClF3NO4S
Molecular Weight
511.94
Precautions
H302, H319
References & Citations
[1]Meunier J, et al. The γ-secretase inhibitor 2-[ (1R) -1-[ (4-chlorophenyl) sulfonyl] (2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's d|[2]Weissmiller AM, et al. A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. PLoS One. 2015 Feb 24;10 (2) :e0118379.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
044931 10 µg
IL-33, Recombinant, Human (Interleukin-33, IL-1F11, NF-HEV)
Sign In for Pricing
View Details 
